The transition between pre-diabetes and early-stage T2D can be difficult to catch in a standard clinical setting and is, at this early stage, reversible [3], with pancreatic beta-cells initially able to compensate for insulin resistance by increasing the amount and duration of insulin secretion. This evidence concerns the gene INS and Insulin resistance.